個案總覽

In April 2013, the co-founder and chief executive officer of Forus Health Private Limited sat in his office in Bangalore, India contemplating the future direction of his company. He was under pressure by his venture capital partner to rapidly penetrate the market for 3nethra — an innovative, multi-functional and low-cost ophthalmology device — before imitators stepped in. Given its features and advantages over expensive imported specialized tools, 3nethra could help address the huge challenge of preventable blindness in India, but after three years since inception, only 100 devices had been sold. Although the market opportunity was large, acceptance by the ophthalmology profession was key to gaining momentum. He had two choices: to maximize sales numbers through the scattergun tactic of going all out and all over the market or to build a sufficient base of positive word of mouth to gain the momentum necessary to pole-vault from the early to the mainstream market. How should he direct his sales team to take the company forward?

In April 2013, the co-founder and chief executive officer of Forus Health Private Limited sat in his office in Bangalore, India contemplating the future direction of his company. He was under pressure by his venture capital partner to rapidly penetrate the market for 3nethra - an innovative, multi-functional and low-cost ophthalmology device - before imitators stepped in. Given its features and advantages over expensive imported specialized tools, 3nethra could help address the huge challenge of preventable blindness in India, but after three years since inception, only 100 devices had been sold. Although the market opportunity was large, acceptance by the ophthalmology profession was key to gaining momentum. He had two choices: to maximize sales numbers through the scattergun tactic of going all out and all over the market or to build a sufficient base of positive word of mouth to gain the momentum necessary to pole-vault from the early to the mainstream market. How should he direct his sales team to take the company forward?

In April 2011, Vithal Gambhir, the marketing director of Vibhava Chemicals, an entrepreneurial venture and leader in the black phenyl category in the home cleaning agents (HCA) market in South India, was faced with a marketing challenge. A slew of multi-national corporation (MNC) brands in the emerging new category of specialty cleaning agents had eroded Vibhava’s share of the traditional black phenyl category by 50 per cent over the previous eight years. The marketing efforts of the MNCs had also led to a gradual transformation of the HCA market, expanding and segmenting it in terms of applications (e.g. floor-cleaning agents and toilet-cleaning agents) and benefits (e.g. disinfecting, cleaning, and deodorizing). As a result, Vibhava’s leading brand, “Black Belt” black phenyl disinfectant, had begun losing ground in the market. Vibhava had successfully responded to this decline by launching Ozone, a pine-oil-based floor cleaner, in 2003. Positioned as an herbal, eco-friendly, deodorizing floor cleaner, Ozone had managed to avert Domex, the leading MNC brand of disinfecting floor cleaner. However, during the last couple of years Domex had been available in many variants serving many segments and the market had become flooded with both MNC and established Indian brands. While the sale of Ozone rose in absolute terms, Vibhava’s share in the growing home cleaning market dropped from 25 per cent in a predominantly traditional product market in the 1990s, to 11 per cent in the transformed market of 2010. Gambhir now faced the daunting challenge of meeting an ambitious sales target of INR 1 billion for 2011-2012, which was double the sales of the previous year.